Atlanta, GA, United States of America

Dwight M Chambers

This inventor holds 1 USPTO granted patent. Top assignees: Emory University, University of Virginia Patent Foundation. Active years: 2023.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Dwight M Chambers

Introduction

Dwight M Chambers is an accomplished inventor based in Atlanta, GA. He has made significant contributions to the field of biotechnology, particularly in the modulation of transforming growth factor-beta (TGF-β) biological activity. His innovative work has implications for various medical applications.

Latest Patents

Dwight M Chambers holds a patent titled "LEMD3 antagonizes TGF-beta-driven Smad2/3 transcription in a stiffness-dependent fashion in both the nucleus and cytosol - Methods and compositions for modulating transforming growth factor-beta (TGF-β) biological activity in a vertebrate subject in need thereof." This patent describes methods that involve administering an effective amount of a substance capable of modulating the activity of LEMD3 in a vertebrate subject to thereby modulate TGF-β biological activity.

Career Highlights

Throughout his career, Dwight has worked with notable institutions such as the University of Virginia Patent Foundation and Emory University. His work has been instrumental in advancing research in the field of biotechnology.

Collaborations

Some of his notable coworkers include Leandro Moretti and Thomas Harrison Barker. Their collaborative efforts have contributed to the success of various projects and innovations.

Conclusion

Dwight M Chambers is a prominent inventor whose work in biotechnology has led to significant advancements in understanding and modulating TGF-β biological activity. His contributions continue to influence the field and pave the way for future innovations.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…